Publication | Closed Access

Gemcitabine and vinorelbine (GV) versus cisplatin, gemcitabine and vinorelbine (CGV) as first-line treatment in advanced non small cell lung cancer: Results of a prospective randomized phase II study

MedicinePhase Ii StudyBronchial NeoplasmFirst-line TreatmentVersus CisplatinCancer TreatmentOncologyRadiation OncologyLung CancerRadiologyHealth Sciences